Small Non-Coding RNA in Breast Cancer Therapy: Yin-Yang

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Breast cancer remains a major global health concern, with systemic chemotherapy as the primary treatment despite significant side effects.
• Personalized treatment strategies are essential for managing breast cancer complexities like metastasis, recurrence, and drug resistance.

Purpose of the Study:

• To explore the potential of small non-coding RNAs in advancing breast cancer diagnosis and therapy.
• To highlight the role of microRNAs (miRNAs) and small interfering RNAs (siRNAs) in cellular regulation and their implications for cancer.

Main Methods:

• Review of recent advancements in understanding small non-coding RNAs and their functions.
• Analysis of existing research on the relationship between miRNAs and cancer, including diagnostic potential.
• Examination of promising therapeutic applications of small non-coding RNAs like Patisiran and Miravirsen.

Main Results:

• Small non-coding RNAs regulate crucial cellular processes, including proliferation, differentiation, metabolism, and cell death.
• miRNAs have demonstrated potential as biomarkers for cancer diagnosis.
• Specific small non-coding RNAs show promise for cancer treatment, though challenges remain.

Conclusions:

• Small non-coding RNAs represent a promising frontier for innovative breast cancer diagnosis and treatment strategies.
• Overcoming challenges in delivery, stability, and off-target activity is critical for realizing the full therapeutic potential of RNA-based interventions.
• Continued research is vital to establish RNA-based therapeutics as effective tools in the fight against breast cancer.